Literature DB >> 29471331

Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.

Dong-Jie Xie1,2, Hai-Song Shi1,2,3, Simon S Y Lui1,4, Chuan Shi5,6,7, Ying Li1,2,8, Karen K Y Ho4, Karen S Y Hung4, Wen-Xiu Li8, Zheng-Hui Yi9, Eric F C Cheung4, Ann M Kring10, Raymond C K Chan1,2.   

Abstract

The Clinical Assessment Interview for Negative Symptoms (CAINS) was designed in accordance with the recent theory and research in social affective neuroscience and to address the psychometric and conceptual limitations of other instruments assessing negative symptoms. The present study aimed to provide a large-scale validation of the CAINS in China and examine its applicability and validity evidence across the schizophrenia spectrum. Using confirmatory factor analysis, our results replicated the original findings in the US development samples that the CAINS possesses a stable 2-factor structure, namely "motivation/pleasure" and "expression". We also found significant correlations between the CAINS and other negative symptom measures. The CAINS demonstrated good discriminant validity in differentiating negative symptoms in people with schizophrenia, nonpsychotic first-degree relatives and people with social anhedonia. People with schizophrenia exhibited significantly higher CAINS subscale scores than first-degree relatives and healthy controls. In addition, first-degree relatives had higher "motivation/pleasure" scores than healthy controls. The "motivation/pleasure" subscale scores of individuals with social anhedonia were also significantly higher than healthy controls.

Entities:  

Mesh:

Year:  2018        PMID: 29471331      PMCID: PMC6188520          DOI: 10.1093/schbul/sby013

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  63 in total

1.  Smooth pursuit and antisaccade performance evidence trait stability in schizophrenia patients and their relatives.

Authors:  Monica E Calkins; William G Iacono; Clayton E Curtis
Journal:  Int J Psychophysiol       Date:  2003-08       Impact factor: 2.997

2.  Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.

Authors:  Jonathan Rabinowitz; Stephen Z Levine; George Garibaldi; Dragana Bugarski-Kirola; Carmen Galani Berardo; Shitij Kapur
Journal:  Schizophr Res       Date:  2012-02-06       Impact factor: 4.939

Review 3.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

4.  Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.

Authors:  J Alexander Bodkin; Samuel G Siris; Paul C Bermanzohn; John Hennen; Jonathan O Cole
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

5.  Anticipatory and consummatory components of the experience of pleasure in schizophrenia: cross-cultural validation and extension.

Authors:  Raymond C K Chan; Ya Wang; Jia Huang; Yanfang Shi; Yuna Wang; Xiaohong Hong; Zheng Ma; Zhanjian Li; M K Lai; Ann M Kring
Journal:  Psychiatry Res       Date:  2009-12-05       Impact factor: 3.222

6.  [International Test Commission Guidelines for test translation and adaptation: second edition].

Authors:  José Muñiz; Paula Elosua; Ronald K Hambleton
Journal:  Psicothema       Date:  2013

7.  Social competence deficits in adolescents at risk for schizophrenia.

Authors:  R H Dworkin; J A Lewis; B A Cornblatt; L Erlenmeyer-Kimling
Journal:  J Nerv Ment Dis       Date:  1994-02       Impact factor: 2.254

Review 8.  Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations.

Authors:  Daniel Freeman; Philippa A Garety
Journal:  Behav Res Ther       Date:  2003-08

9.  Neural correlates of sad feelings in schizophrenia with and without blunted affect.

Authors:  Emmanuel Stip; Cherine Fahim; Peter Liddle; Adham Mancini-Marïe; Boualem Mensour; Lahcen Ait Bentaleb; Mario Beauregard
Journal:  Can J Psychiatry       Date:  2005-12       Impact factor: 4.356

Review 10.  Is Schizotypy per se a Suitable Endophenotype of Schizophrenia? - Do Not Forget to Distinguish Positive from Negative Facets.

Authors:  Phillip Grant
Journal:  Front Psychiatry       Date:  2015-10-23       Impact factor: 4.157

View more
  10 in total

1.  Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Ruth Lorente-Omeñaca; Lucía Moreno-Izco; Victor Peralta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-09-07       Impact factor: 5.270

2.  Negative schizotypal traits predict the reduction of reward motivation in effort-reward imbalance.

Authors:  Yong-Jie Yan; Hui-Xin Hu; Ling-Ling Wang; Yi-Jing Zhang; Simon S Y Lui; Jia Huang; Raymond C K Chan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-31       Impact factor: 5.270

3.  Bridge centrality network structure of negative symptoms in people with schizophrenia.

Authors:  Ling-Ling Wang; Michelle H W Tam; Karen K Y Ho; Karen S Y Hung; Jessica O Y Wong; Simon S Y Lui; Raymond C K Chan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-16       Impact factor: 5.760

4.  Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Ian M Raugh; Luyu Zhang; Lauren Luther; Hannah C Chapman; Daniel N Allen; Brian Kirkpatrick; Alex S Cohen
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-15

5.  The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis.

Authors:  Hui-Xin Hu; Wilson Y S Lau; Eugenia P Y Ma; Karen S Y Hung; Si-Yu Chen; Kin-Shing Cheng; Eric F C Cheung; Simon S Y Lui; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

6.  Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.

Authors:  Gregory P Strauss; Farnaz Zamani Esfahlani; Silvana Galderisi; Armida Mucci; Alessandro Rossi; Paola Bucci; Paola Rocca; Mario Maj; Brian Kirkpatrick; Ivan Ruiz; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

7.  Validation of the French Clinical Assessment Interview for Negative Symptoms in a Sample of Stable French Individuals With Schizophrenia.

Authors:  Yasmine Laraki; Cindy Lebrun; Marine Merenciano; Margot Eisenblaetter; Jerôme Attal; Alexandra Macgregor; Amandine Decombe; Delphine Capdevielle; Stéphane Raffard
Journal:  Front Psychiatry       Date:  2022-04-01       Impact factor: 4.157

8.  Validation of the Chinese Version of the 16-Item Negative Symptom Assessment.

Authors:  Bing-Jie Huang; Yong Wang; Qi Miao; Xin Yu; Cheng-Cheng Pu; Chuan Shi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-04       Impact factor: 2.570

9.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

10.  What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic Review.

Authors:  Bernardo Haguiara; Gabriela Koga; Elton Diniz; Lais Fonseca; Cinthia H Higuchi; Simão Kagan; Acioly Lacerda; Christoph U Correll; Ary Gadelha
Journal:  Schizophr Bull Open       Date:  2021-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.